Biomarin Pharmaceutical Inc (BMRN) — Tangible Net Worth Ratio
Biomarin Pharmaceutical Inc (BMRN) has a Tangible Net Worth Ratio of 22.8% as of June 2026. This metric is calculated by deducting intangible assets ($4.88 Billion) from net assets ($6.32 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Biomarin Pharmaceutical Inc equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Biomarin Pharmaceutical Inc Tangible Net Worth Ratio (1998–2025)
This chart shows how Biomarin Pharmaceutical Inc's Tangible Net Worth Ratio has changed across 26 annual periods from 1998 to 2025. As of June 2026, the ratio stands at 22.8%, reflecting net assets of $6.32 Billion with intangible assets of $4.88 Billion USD. For live market cap and overall valuation, see how much is Biomarin Pharmaceutical Inc worth.
Annual Tangible Net Worth Ratio for Biomarin Pharmaceutical Inc (1998–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Biomarin Pharmaceutical Inc from 1998 to 2025, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Biomarin Pharmaceutical Inc to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $6.09 Billion | $213.84 Million | $7.59 Billion | ▲ +1.0 pp |
| 2024 | 95.5% | $5.66 Billion | $255.28 Million | $6.99 Billion | ▲ +1.4 pp |
| 2023 | 94.0% | $4.95 Billion | $294.70 Million | $6.84 Billion | ▲ +1.4 pp |
| 2022 | 92.6% | $4.60 Billion | $338.57 Million | $6.38 Billion | ▲ +1.7 pp |
| 2021 | 90.9% | $4.27 Billion | $388.65 Million | $6.00 Billion | ▲ +1.1 pp |
| 2020 | 89.8% | $4.11 Billion | $417.27 Million | $5.85 Billion | ▲ +4.5 pp |
| 2019 | 85.4% | $3.12 Billion | $456.58 Million | $4.69 Billion | ▲ +1.9 pp |
| 2018 | 83.4% | $2.97 Billion | $491.81 Million | $4.43 Billion | ▲ +1.9 pp |
| 2017 | 81.6% | $2.81 Billion | $517.51 Million | $4.63 Billion | ▲ +1.6 pp |
| 2016 | 80.0% | $2.77 Billion | $553.78 Million | $4.02 Billion | ▲ +8.5 pp |
| 2015 | 71.5% | $2.40 Billion | $684.00 Million | $3.73 Billion | ▼ -18.2 pp |
| 2014 | 89.8% | $1.53 Billion | $156.58 Million | $2.49 Billion | ▲ +1.9 pp |
| 2013 | 87.8% | $1.34 Billion | $163.15 Million | $2.24 Billion | ▲ +3.9 pp |
| 2012 | 84.0% | $1.02 Billion | $162.98 Million | $1.57 Billion | ▲ +7.3 pp |
| 2011 | 76.7% | $773.05 Million | $180.28 Million | $1.31 Billion | ▼ -8.9 pp |
| 2010 | 85.5% | $717.26 Million | $103.65 Million | $1.26 Billion | ▼ -1.7 pp |
| 2009 | 87.3% | $322.19 Million | $40.98 Million | $917.16 Million | ▼ -10.0 pp |
| 2008 | 97.2% | $276.68 Million | $7.63 Million | $906.70 Million | ▲ +2.4 pp |
| 2007 | 94.9% | $187.73 Million | $9.60 Million | $815.28 Million | ▲ +4.8 pp |
| 2006 | 90.1% | $117.80 Million | $11.65 Million | $463.44 Million | ▼ -9.9 pp |
| 2003 | 100.0% | $117.85 Million | $0.00 | $256.34 Million | ▲ +0.0 pp |
| 2002 | 100.0% | $98.54 Million | $0.00 | $110.62 Million | ▲ +0.0 pp |
| 2001 | 100.0% | $159.55 Million | $0.00 | $171.81 Million | ▲ +14.1 pp |
| 2000 | 85.9% | $69.99 Million | $9.86 Million | $76.93 Million | ▼ -2.4 pp |
| 1999 | 88.3% | $98.38 Million | $11.46 Million | $103.55 Million | ▲ +28.1 pp |
| 1998 | 60.2% | $29.40 Million | $11.70 Million | $31.51 Million | — |